Patient Assistance Programs for Rituxan. Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Full Answer
What is the Rituxan immunology co-pay program?
Rituxan Immunology Access Solutions can refer eligible patients to the Rituxan Immunology Co-pay Program for help with the out-of-pocket costs associated with Rituxan.* For eligible patients with commercial or public health insurance, Rituxan Immunology Access Solutions offers referrals to independent co-pay assistance foundations.†
How can I get help paying for Rituxan?
Visit Genentech-Access.com/RITUXAN. Genentech offers the Genentech Oncology Co-pay Assistance Program that may help you with the out-of-pocket costs of RITUXAN.*
What is Genentech access solutions for Rituxan?
Genentech Access Solutions is a program that helps people who are taking RITUXAN. Your health insurance plan and the cost of your medicine might keep you from getting your prescribed treatment. We may be able to help. To learn more about Genentech Access Solutions, call (888) 249-4918 or visit Genentech-Access.com/RITUXAN.
Is Rituxan available without a prescription?
RITUXAN is available by prescription only. What is RITUXAN? Non-Hodgkin’s Lymphoma (NHL): alone or with other chemotherapy medicines. Chronic Lymphocytic Leukemia (CLL): with the chemotherapy medicines fludarabine and cyclophosphamide. It is not known if RITUXAN is safe and effective in children with CLL.
How do you feel after Rituxan?
After a Rituxan (rituximab) infusion you may experience certain side effects or adverse reactions that make you feel unwell. Rituxan affects different people in different ways, but the more common side effects include: Fever (high temperature), muscle aches, headaches and chills, which are signs of infection.
Can you drink after rituximab infusion?
Alcohol. There's no need to avoid alcohol while taking rituximab. You're advised to stick within the guidelines of drinking no more than 14 units a week and that they should spread them out over the course of the week. In some cases, your doctor may advise lower limits.
What is Genentech Patient Foundation?
The Genentech Patient Foundation gives free Genentech medicine to people who don't have insurance coverage or who have financial concerns and meet eligibility criteria.
Is Rituxan a Part B drug?
That made Rituxan – approved to treat non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis – one of six drugs to exceed $1 billion in spending by Medicare part B for the year.
Will I lose my hair with rituximab?
You could lose all your hair. This includes your eyelashes, eyebrows, underarm, leg and sometimes pubic hair. Your hair will usually grow back once treatment has finished but it is likely to be softer. It may grow back a different colour or be curlier than before.
Why am I so tired after Rituxan?
Serious side effects that can occur with Rituxan include: tumor lysis syndrome (nausea, vomiting, diarrhea, and tiredness that happen due to tumor cells breaking down and releasing their contents into your blood)
What drugs does Genentech make?
Our Medicines & ProductsMedicines.Actemra® (TOCILIZUMAB [authorized for Emergency Use])Actemra® (tocilizumab)Activase® (alteplase)Alecensa® (alectinib)Avastin® (bevacizumab)Boniva Tablets® (ibandronate sodium)Cathflo Activase® (alteplase)More items...
Who makes Valganciclovir?
Genentech: Valcyte® (valganciclovir hydrochloride) - Information for Patients.
Does Medicare require a prior authorization for Rituxan?
Prior authorization is required for all treatment with necessary Rituximab (Rituxan®, Truxima®, RiabniTM, RuxienceTM) requested for members enrolled in Harvard Pilgrim StrideSM (HMO) Medicare Advantage.
Where can I get Rituxan?
Authorized Distributors and Specialty PharmaciesDistributorTelephoneFaxCardinal Health Specialty Distribution877-453-3972614-652-7043CenterWell Specialty Pharmacy800-486-2668877-405-7940CuraScript SD877-599-7748800-862-6208McKesson Specialty Health800-482-6700 855-477-9700 (Non-Oncology Customers)800-289-92853 more rows
What is Rituxan infusion?
RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (NHL): alone or with other chemotherapy medicines. Adults with Chronic Lymphocytic Leukemia (CLL): with the chemotherapy medicines fludarabine and cyclophosphamide.
How long does it take for B-cells to heal after RITUXAN?
Treatment with rituximab results in complete B cell-depletion within 72 h. Recovery of B cell counts usually starts only 6-9 months after the completion of therapy, and normal levels are obtained after 9-12 months (5).
How long does rituximab suppress immune system?
Immune reconstitution starts usually after six months with recovery to normal between nine to twelve months. Extended rituximab treatment results in a prolonged recovery of B-cells without an increase of clinically relevant infections.
How long does it take for rituximab to take effect?
Rituximab takes 2-6 weeks to take effect. Rituximab does not cure the condition and you may need to take it for several years to keep your relapses under control.
How long does rituximab infusion take?
Total minimum infusion time for the first infusion is 4 hours and 15 minutes, plus 15 minutes for the flush. Total minimum infusion time for subsequent infusions is 3 hours and 15 minutes, plus 15 minutes for the flush.
How long after Rituxan infusion can you have a reaction?
Infusion-Related Reactions: Infusion-related reactions are very common side effects of Rituxan treatment. Serious infusion-related reactions can happen during your infusion or within 24 hours after your infusion of Rituxan. Your healthcare provider should give you medicines before your infusion of Rituxan to decrease your chance of having a severe infusion-related reaction.
How to report side effects of Genentech?
Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at (800) FDA‐1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835‐2555.
Can you test if you are pregnant before taking Rituxan?
Your healthcare provider should do a pregnancy test to see if you are pregnant before starting Rituxan.
Does Rituxan cause heart problems?
Heart Problems: Rituxan may cause chest pain, irregular heartbeats, and heart attack. Your healthcare provider may monitor your heart during and after treatment with Rituxan if you have symptoms of heart problems or have a history of heart problems. Tell your healthcare provider right away if you have chest pain or irregular heartbeats during treatment with Rituxan
Where to report RITUXAN side effects?
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch . You may also report side effects to Genentech at (888) 835-2555.
What to tell your healthcare provider before taking Rituximab?
Before receiving RITUXAN, tell your healthcare provider if you: Have had a severe reaction to RITUXAN or a rituximab product. Have a history of heart problems, irregular heartbeat, or chest pain. Have lung or kidney problems. Have had an infection, currently have an infection, or have a weakened immune system.
How long after a last dose of Rituxan can you give birth?
Females who are able to become pregnant should use effective birth control (contraception) during treatment with RITUXAN and for 12 months after the last dose of RITUXAN.
What to do before a Rituxan infusion?
Your healthcare provider should give you medicines before your infusion of RITUXAN to decrease your chance of having a severe infusion-related reactions. Tell your healthcare provider or get medical help right away if you get any of these symptoms during or after an infusion of RITUXAN: Hives (red itchy welts) or rash.
How long after a Rituxan can you breastfeed?
Are breastfeeding or plan to breastfeed. It is not known if RITUXAN passes into your breast milk. Do not breastfeed during treatment and for at least 6 months after your last dose of RITUXAN. Are taking any medications, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
How long after a Rituxan infusion do you have a reaction?
Serious infusion-related reactions can happen during your infusion or within 24 hours after your infusion of RITUXAN.
What does it feel like to have a rituxan?
Severe Skin and Mouth Reactions: Tell your healthcare provider or get medical help right away if you get any of these symptoms at any time during your treatment with RITUXAN: Painful sores or ulcers on your skin, lips, or in your mouth. Blisters.
What is the rate of serious infections with Rituxan?
In the experience with Rituxan in 2578 RA patients, the rate of serious infection was 4.31 per 100 patient-years. The most common serious infections (≥0.5%) were pneumonia or lower respiratory tract infections, cellulitis, and urinary tract infections. Fatal serious infections included pneumonia, sepsis, and colitis. Rates of serious infection remain stable in patients receiving subsequent courses.
What is the most common infection with Rituxan?
The most common serious infection was pneumonia. Hypogammaglobulinemia: Hypogammaglobulinemia (IgA, IgG, or IgM below the lower limit of normal) has been observed in patients with GPA and MPA treated with Rituxan in GPA/MPA Study 1.
How long after Rituxan infusion do you have an adverse reaction?
Infusion-Related Reactions: In the Rituxan RA pooled, placebo-controlled studies, incidence of any adverse event within 24 hours of an infusion was 32% vs 23% after the first infusion, and 11% vs 13% after the second infusion in the Rituxan-treated patients and placebo group, respectively. Incidence of acute infusion-related reactions was 27% vs 19% after the first infusion, 9% vs 11% after the second infusion in the Rituxan-treated patients and placebo group, respectively. Serious acute infusion-related reactions were experienced by <1% of patients in either treatment group. Acute infusion-related reactions required dose modification (stopping, slowing, or interruption of the infusion) in 10% and 2% of patients receiving Rituxan or placebo, respectively, after the first course.
How long before a course of Rituxan can you administer non live shots?
For patients treated with Rituxan, physicians should review the patient’s vaccination status and patients should, if possible, be brought up to date with all immunizations in agreement with current immunization guidelines prior to initiating Rituxan and administer non-live vaccines at least 4 weeks prior to a course of Rituxan.
How long does it take for a PV to test positive for Rituximab?
Using a new ELISA assay, a total of 19/34 (56%) patients with PV treated with the Ritux 3 regimen tested positive for anti-rituximab antibodies by 18 months. The clinical relevance of anti-rituximab antibody formation in Rituxan treated PV patients is unclear.
How many patients tested positive for anti-rituximab?
A total of 273/2578 (11%) patients with RA tested positive for anti-rituximab antibodies at any time after receiving Rituxan. Anti-rituximab antibody positivity was not associated with increased infusion-related reactions or other adverse reactions. Upon further treatment, the proportions of patients with infusion-related reactions were similar between anti-rituximab antibody positive and negative patients, and most reactions were mild to moderate. Four anti-rituximab antibody positive patients had serious infusion-related reactions, and the temporal relationship between anti-rituximab antibody positivity and infusion-related reaction was variable. The clinical relevance of anti-rituximab antibody formation in Rituxan-treated patients is unclear.
Can you have mucocutaneous reactions with Rituxan?
Severe Mucocutaneous Reactions: Severe, including fatal, mucocutaneous reactions can occur in patients receiving Rituxan. These reactions include paraneoplastic pemphigus, Stevens-Johnson syndrome, lichenoid dermatitis, vesiculobullous dermatitis, and toxic epidermal necrolysis. The onset of these reactions has been variable and includes reports with onset on the first day of Rituxan exposure. Discontinue Rituxan in patients who experience a severe mucocutaneous reaction. The safety of readministration of Rituxan to patients with severe mucocutaneous reactions has not been determined.
What is the rate of serious infections with Rituxan?
In the experience with Rituxan in 2578 RA patients, the rate of serious infection was 4.31 per 100 patient-years. The most common serious infections (≥0.5%) were pneumonia or lower respiratory tract infections, cellulitis, and urinary tract infections. Fatal serious infections included pneumonia, sepsis, and colitis. Rates of serious infection remain stable in patients receiving subsequent courses.
What is the most common infection in Rituxan?
The incidence of serious infections was 11% vs 10% (Rituxan-treated vs cyclophosphamide, respectively), with rates of approximately 25 and 28 per 100 patient-years, respectively. The most common serious infection was pneumonia.
How long after Rituxan infusion do you have an adverse reaction?
Infusion-Related Reactions: In the Rituxan RA pooled, placebo-controlled studies, incidence of any adverse event within 24 hours of an infusion was 32% vs 23% after the first infusion, and 11% vs 13% after the second infusion in the Rituxan-treated patients and placebo group, respectively. Incidence of acute infusion-related reactions was 27% vs 19% after the first infusion, 9% vs 11% after the second infusion in the Rituxan-treated patients and placebo group, respectively. Serious acute infusion-related reactions were experienced by <1% of patients in either treatment group. Acute infusion-related reactions required dose modification (stopping, slowing, or interruption of the infusion) in 10% and 2% of patients receiving Rituxan or placebo, respectively, after the first course.
How long before a course of Rituxan can you administer non live shots?
For patients treated with Rituxan, physicians should review the patient’s vaccination status and patients should, if possible, be brought up to date with all immunizations in agreement with current immunization guidelines prior to initiating Rituxan and administer non-live vaccines at least 4 weeks prior to a course of Rituxan.
How long does it take for a PV to test positive for Rituximab?
Using a new ELISA assay, a total of 19/34 (56%) patients with PV treated with the Ritux 3 regimen tested positive for anti-rituximab antibodies by 18 months. The clinical relevance of anti-rituximab antibody formation in Rituxan treated PV patients is unclear.
How many patients tested positive for anti-rituximab?
A total of 273/2578 (11%) patients with RA tested positive for anti-rituximab antibodies at any time after receiving Rituxan. Anti-rituximab antibody positivity was not associated with increased infusion-related reactions or other adverse reactions. Upon further treatment, the proportions of patients with infusion-related reactions were similar between anti-rituximab antibody positive and negative patients, and most reactions were mild to moderate. Four anti-rituximab antibody positive patients had serious infusion-related reactions, and the temporal relationship between anti-rituximab antibody positivity and infusion-related reaction was variable. The clinical relevance of anti-rituximab antibody formation in Rituxan-treated patients is unclear.
Can you have mucocutaneous reactions with Rituxan?
Severe Mucocutaneous Reactions: Severe, including fatal, mucocutaneous reactions can occur in patients receiving Rituxan. These reactions include paraneoplastic pemphigus, Stevens-Johnson syndrome, lichenoid dermatitis, vesiculobullous dermatitis, and toxic epidermal necrolysis. The onset of these reactions has been variable and includes reports with onset on the first day of Rituxan exposure. Discontinue Rituxan in patients who experience a severe mucocutaneous reaction. The safety of readministration of Rituxan to patients with severe mucocutaneous reactions has not been determined.
What is rituximab used for?
Rituximab is a type of medication called a monoclonal antibody. It is used to treat certain types of cancer (e.g., non- Hodgkin's lymphoma).
Can rituximab cause heart problems?
WARNING: Rarely, serious (even fatal) side effects have occurred with rituximab use. Side effects such as breathing trouble, chest pain, irregular heartbeats, or a large change in amount of urine must be reported to your doctor immediately. Your doctor may stop rituximab or use additional treatment. Laboratory tests (e.g., electrolytes, kidney function) may be performed to monitor your progress. If you have heart or lung problems, a large number of cancer cells (above 25,000/mm3) in the blood, or certain cancers (CLL or lymphoma), you should be closely monitored.
